Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Sell
7,135
-459
-6% -$143K 0.01% 960
2026
Q1
$2.22M Buy
7,594
+643
+9% +$207K 0.01% 859
2025
Q4
$1.98M Buy
6,951
+326
+5% +$92.6K 0.01% 862
2025
Q3
$1.96M Buy
6,625
+160
+2% +$52.2K 0.01% 762
2025
Q2
$2.04M Buy
6,465
+151
+2% +$47.3K 0.02% 661
2025
Q1
$2.12M Buy
6,314
+230
+4% +$83.5K 0.02% 523
2024
Q4
$2.14M Buy
+6,084
New +$2.21M 0.03% 480

Other funds holding KAI

&Partners's KAI Position: Q2 2026 in Review

&Partners reduced its Kadant (KAI) stake by 6% in Q2 2026, selling an estimated $143K and leaving 7,135 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #960.

&Partners first reported a position in KAI in Q4 2024 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

  • &Partners held 7,135 shares of Kadant worth $2.24M as of Q2 2026.
  • &Partners sold 459 Kadant shares in Q2 2026, an estimated $143K.
  • Kadant made up 0.01% of &Partners's portfolio in Q2 2026, its #960 holding.
  • &Partners first reported a position in Kadant in Q4 2024 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.